Mir-125a-3p can downregulate VEGF expression under the activation of PinX1 (PIN2/TRF1-interacting telomerase inhibitor 1), thereby inhibiting RCC angiogenesis and thus inhibiting RCC progression (Hou et al., 2019). The gene discussed is PINX1; the disease is renal cell adenocarcinoma.